1. Dapagliflozin in patients with type 2 diabetes receiving high doses of insulin: efficacy and safety over 2 years. Issue 2 (29th August 2013) Authors: Wilding, J. P. H.; Woo, V.; Rohwedder, K.; Sugg, J.; Parikh, S. Journal: Diabetes, obesity & metabolism Issue: Volume 16:Issue 2(2014:Feb.) Page Start: 124 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin. Issue 2 (29th August 2013) Authors: Bolinder, J.; Ljunggren, Ö.; Johansson, L.; Wilding, J.; Langkilde, A. M.; Sjöström, C. D.; Sugg, J.; Parikh, S. Journal: Diabetes, obesity & metabolism Issue: Volume 16:Issue 2(2014:Feb.) Page Start: 159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Dapagliflozin‐induced weight loss affects 24‐week glycated haemoglobin and blood pressure levels. Issue 8 (27th June 2015) Authors: Sjöström, C. D.; Hashemi, M.; Sugg, J.; Ptaszynska, A.; Johnsson, E. Journal: Diabetes, obesity & metabolism Issue: Volume 17:Issue 8(2015:Aug.) Page Start: 809 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Durability and tolerability of dapagliflozin over 52 weeks as add‐on to metformin and sulphonylurea in type 2 diabetes. Issue 11 (4th September 2015) Authors: Matthaei, S.; Bowering, K.; Rohwedder, K.; Sugg, J.; Parikh, S.; Johnsson, E.; on behalf of the Study 05 Group Journal: Diabetes, obesity & metabolism Issue: Volume 17:Issue 11(2015:Nov.) Page Start: 1075 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Durability of glycaemic efficacy over 2 years with dapagliflozin versus glipizide as add‐on therapies in patients whose type 2 diabetes mellitus is inadequately controlled with metformin†. Issue 11 (10th July 2014) Authors: Nauck, M. A.; Del Prato, S.; Durán‐García, S.; Rohwedder, K.; Langkilde, A. M.; Sugg, J.; Parikh, S. J. Journal: Diabetes, obesity & metabolism Issue: Volume 16:Issue 11(2014:Nov.) Page Start: 1111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Patient‐reported outcomes among patients with type 2 diabetes mellitus treated with dapagliflozin in a triple‐therapy regimen for 52 weeks. Issue 3 (5th January 2016) Authors: Grandy, S.; Sternhufvud, C.; Ryden, A.; Sugg, J.; Rohwedder, K. Journal: Diabetes, obesity & metabolism Issue: Volume 18:Issue 3(2016) Page Start: 306 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗